1. Home
  2. PSX vs EW Comparison

PSX vs EW Comparison

Compare PSX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phillips 66

PSX

Phillips 66

N/A

Current Price

$169.38

Market Cap

62.8B

Sector

Energy

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$85.22

Market Cap

50.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSX
EW
Founded
1875
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.8B
50.2B
IPO Year
2011
1999

Fundamental Metrics

Financial Performance
Metric
PSX
EW
Price
$169.38
$85.22
Analyst Decision
Buy
Buy
Analyst Count
19
21
Target Price
$147.05
$96.47
AVG Volume (30 Days)
2.3M
4.7M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
3.13%
N/A
EPS Growth
116.23
N/A
EPS
10.79
1.83
Revenue
$132,376,000,000.00
$6,067,600,000.00
Revenue This Year
N/A
$13.39
Revenue Next Year
$2.57
$9.78
P/E Ratio
$15.04
$46.87
Revenue Growth
N/A
11.55
52 Week Low
$91.01
$65.94
52 Week High
$169.62
$87.89

Technical Indicators

Market Signals
Indicator
PSX
EW
Relative Strength Index (RSI) 69.10 56.48
Support Level $127.98 $81.61
Resistance Level N/A $87.22
Average True Range (ATR) 4.70 2.16
MACD 0.43 0.30
Stochastic Oscillator 97.61 76.96

Price Performance

Historical Comparison
PSX
EW

About PSX Phillips 66

Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 1.9 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: